Biomarker for diagnosing cerebral infarction of white matter lesion patient and application of biomarker
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BAO FENG BIOTECH (BEIJING) CO LTD
- Publication Date
- 2021-09-28
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biological detection, and in particular relates to a biomarker for diagnosing cerebral infarction in patients with leukoencephalopathy and its application. Background technique
[0002] With the aging of society, the incidence of stroke has increased sharply, and the incidence of stroke in our country is higher than the international average level. Among them, ischemic stroke (cerebral infarction) is caused by the stenosis or occlusion of cerebral arteries resulting in the loss of brain tissue. Blood necrosis accounts for more than 70% of all strokes. White matter lesion (WML) is a common neurodegenerative disease, the most typical pathological manifestations are damage to the integrity of white matter or demyelination, which is common in stroke, Parkinson's disease, Alzheimer's disease Alzheimer's disease, multiple sclerosis, schizophrenia and many other diseases. The typical response of white matter t...